BioAge Labs | Targeting metabolic aging
WEBJun 21, 2024 · Our human-first discovery platform analyzes proprietary multi-omics data captured over decades to identify the molecular mediators of aging and disease. Our pipeline programs target key pathways that drive metabolic aging based on novel insights from our platform.
BioAge Labs | Company
WEBBioAge takes a human-centric, data-driven approach to identify the molecular features of healthy aging and reveal the causes of age-related diseases. By targeting aging with a large and mechanistically diverse portfolio of drugs, we will unlock opportunities to treat or even prevent these diseases in entirely new ways.
Events | BioAge Labs, Inc.
WEBStay up to date with BioAge Labs, Inc.'s investor events.
Presentations | BioAge Labs, Inc.
WEBPresentations. June 21, 2024. BioAge - ADA Scientific Sessions. View BioAge Labs, Inc.'s investor presentations.
BioAge Labs | Events - Discovery
WEBApr 29, 2024 · NASDAQ tower announcement. On the big screen in Times Square, NASDAQ helps us celebrate our $170M Series D to accelerate clinical development for obesity therapeutics. The BioAge mission is to extend healthy lifespan by developing treatments that target the molecular causes of human aging.
BioAge Labs | About us - Discovery
WEBOur leadership team has diverse professional experience across the biopharma ecosystem and an established track record of success, involved in 95+ regulatory approvals.
BioAge Labs | Pipeline - Discovery
WEBOur lead program, azelaprag, has potential to be a first and best-in-class oral weight loss therapy co-administered with GLP-1 to achieve injectable-like total weight loss and improved body composition.
BioAge Labs | About Aging - Discovery
WEBImpaired immunity increases hospitalization and death from infections and decreases vaccine efficacy in the elderly. Persistent inflammation impairs immunity while worsening chronic diseases— increasing frailty, morbidity, and the risk of premature death.
BioAge Labs Announces Pricing of Upsized Initial Public Offering
WEBRICHMOND, Calif., Sept. 25, 2024 (GLOBE NEWSWIRE) -- BioAge Labs, Inc. (“BioAge”) (Nasdaq: BIOA), a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of aging, today announced the pricing of its.
BioAge Labs | Careers - Discovery
WEBBioAge is committed to discovering new drugs for metabolic disease through the lens of aging biology — improving wellness throughout the lifespan and helping people enjoy longer, healthier lives. We are always seeking talented individuals who share our passion to join us in our mission.
- Some results have been removed